Navigation Links
A Bright Future for Medicare Beneficiaries in Maine
Date:1/29/2008

SOUTH PORTLAND, Maine, Jan. 29 /PRNewswire/ -- Arcadian Health Plan, Inc., a leading provider of Medicare Advantage health plans for Medicare beneficiaries, has enhanced its benefits for 2008 and further expanded into the state of Maine. This comes on the heels of successful rollouts in Oklahoma, Louisiana, and South Carolina.

Highlights of these plans include low or no premiums in most markets, free annual physicals and flu shots, dental benefits, and an ever-expanding provider and hospital network.

"We've been met with enthusiasm from the Medicare population," said Dr. John Austin, chairman of Arcadian Health Plan, Inc. "Medicare is in the midst of historic changes, and Arcadian Health Plan is dedicated to helping people understand their options. We think our growth is due in large part to this education."

Dr. Austin went on to say that Arcadian Health Plan is entering a new market in northern Maine covering Hancock and Penobscot counties and has expanded the southern Maine coverage area to include Androscoggin, Sagadahoc and York counties. Arcadian Health Plan, Inc. operates locally in Maine as Northeast Community Care.

"Arcadian Health Plan's goal has always been to choose mid-size to smaller markets to enter so that we're able to interact with members and health care providers on a personal level," said Garrison Rios, Chief Marketing Officer for Arcadian Health Plan. "We believe our growth is attributable to this commitment, and we look forward to taking this commitment into Maine."

When Congress modernized Medicare laws in 2003, the private sector was given a greater role in administering Medicare services. In addition to regular Medicare, beneficiaries can now choose to enroll in Medicare Advantage plans. These follow a managed-care model that using a network of local doctors and hospitals that enrollees can choose. This model can reduce health care costs while ensuring excellent care and access to specialists.

'/>"/>
SOURCE Arcadian Health Plan, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Bright tumors, dim prospects
2. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
3. Experts Agree. Ohios Technology Investment Future Looks Bright
4. Laser Energetics Delivers BrightStar(TM) Alexandrite Laser to Fortune 50 Defense Company
5. Jane Fonda and Bright Starts(TM) Celebrates Pink Power Moms at Susan G. Komen for the Cure Pink Tie Ball
6. MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS
7. Bright Medical Associates Selects InteGreat EHR for Ease of Use
8. Brighton Hospital Announces Creation of Brighton National Addiction Foundation
9. Campaign for Americas Future Memorandum: Katrina Storm Warning
10. Shipcom Partners With DOKUMENTA for METROs Future Store Initiative
11. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 1New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 2New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 3New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 4Outpatient disc treatment gives long term back pain relief 62403 1Outpatient disc treatment gives long term back pain relief 62403 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 1State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 3